NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1041200090

Registered date:06/01/2021

Comparison of therapeutic effects of denosumab and romosozumab using Propensity Score Matching in postmenopausal osteoporosis patients

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedPrimary osteoprosis
Date of first enrollment01/04/2018
Target sample size150
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeBone density chang e (lumbar spine)
Secondary OutcomeBone density(total hip, femoral neck),Bone metabolic marker

Key inclusion & exclusion criteria

Age minimum>= 45age old
Age maximum<= 100age old
GenderFemale
Include criteriaprimary osteoporosis
Exclude criteria1. Previous romosozumab or denosumab use. 2. hypocalcemia 3. Cardiovascular events within 1 year 4. Pregnant or lactating women, those who wish to become pregnant 5. Patients judg ed to be inappropriate for study

Related Information

Contact

Public contact
Name Tomonori Kobayakawa
Address 1969 Kunou fukuroi city shizuoka Shizuoka Japan 436-0061
Telephone +81-538-43-5800
E-mail kobatomo0109@yahoo.co.jp
Affiliation Kobayakawa Orthopedic and Rheumatologic clinic
Scientific contact
Name Tomonori Kobayakawa
Address 1969 Kunou fukuroi city shizuoka Shizuoka Japan 437-0061
Telephone +81-538-43-5800
E-mail kobatomo0109@yahoo.co.jp
Affiliation Kobayakawa Orthopedic and Rheumatologic clinic